Format

Send to

Choose Destination
Trends Pharmacol Sci. 2011 Apr;32(4):242-9. doi: 10.1016/j.tips.2011.01.003. Epub 2011 Feb 15.

Histamine receptors in the CNS as targets for therapeutic intervention.

Author information

1
Dipartimento di Farmacologia Preclinica e Clinica,Viale Pieraccini 6, 50139 Firenze (I), Italy. beatrice.passani@unifi.it

Abstract

Histamine has long been known to trigger allergic reactions and gastric acid secretion. However, it was later discovered that, in the brain, histamine regulates basic homeostatic and higher functions, including cognition, arousal, circadian and feeding rhythms. The sole source of brain histamine is neurons localized in the hypothalamic tuberomammillary nuclei. These neurons project axons to the whole brain, are organized into functionally distinct circuits influencing different brain regions and display selective control mechanisms. Although all histamine receptors (H1R, H2R, H3R and H4R) are expressed in the brain, only the H3R has become a drug target for the treatment of neurologic and psychiatric disorders, such as sleep disturbances and cognitive deficits. In this review, we discuss recent developments in the pharmacological manipulation of H3Rs and the implications for H3R-related therapies for neurological and psychiatric disorders. The legacy of Sir James Black.

PMID:
21324537
DOI:
10.1016/j.tips.2011.01.003
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center